Welcome to our dedicated page for Hyster-Yale SEC filings (Ticker: HY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating how much Hyster-Yale spent on hydrogen fuel-cell R&D or when executives last bought shares often means wading through hundreds of pages. Stock Titan turns every Hyster-Yale filing into an easy read, delivering AI-powered summaries that surface the lift-truck backlog, regional demand shifts and cash-flow changes in seconds.
Need the Hyster-Yale quarterly earnings report 10-Q filing or want to monitor Hyster-Yale insider trading Form 4 transactions? We stream documents from EDGAR the moment they post and translate them into clear takeaways. Our platform links each disclosure type to the metric you care about:
- Form 4 alerts highlight Hyster-Yale executive stock transactions Form 4 in real time.
- 10-Ks are annotated so the Hyster-Yale annual report 10-K simplified shows segment margins and dealer-financing risk at a glance.
- 8-Ks flag material events—see Hyster-Yale 8-K material events explained minutes after filing.
- DEF 14A reports decode Hyster-Yale proxy statement executive compensation without legal jargon.
Our AI answers the questions investors actually ask—“How cyclical is lift-truck demand?” or “What’s hidden in the warranty reserve footnote?”—while embedding long-tail queries like Hyster-Yale SEC filings explained simply, understanding Hyster-Yale SEC documents with AI, and Hyster-Yale earnings report filing analysis. From Hyster-Yale Form 4 insider transactions real-time to nuanced Bolzoni attachment revenue trends, every disclosure is parsed so you can act faster and invest smarter.
Hyster-Yale, Inc. (HY) – Form 4 insider filing dated 07/01/2025
Director Carolyn Corvi received 948 Class A common shares under the company’s Non-Employee Directors’ Equity Compensation Plan at a stated price of $0 per share. The award lifts her direct ownership to 25,222 shares. No derivative securities were involved and the filing lists the transaction code “A” (award/grant). Because the shares were granted, not purchased on the open market, the filing primarily reflects routine director compensation rather than an active investment decision.
- Reporting person: Carolyn Corvi, outside director
- Transaction type: Equity award (“A” code)
- Transaction date: 07/01/2025
- Total shares now owned directly: 25,222
- Indicates continued board-level equity alignment but minimal financial impact to HY
Hyster-Yale (HY) has filed a Form 4 reporting that director Britton T. Taplin acquired 948 Class A common shares on 1 July 2025. The shares were issued at $0.00 under the company’s Non-Employee Directors’ Equity Compensation Plan (transaction code “A”), indicating a routine board compensation grant rather than an open-market purchase. After the award, Taplin reports 386,154 shares held indirectly through trusts and LLCs, plus several smaller family-related positions. No shares were sold and no derivative securities were exercised or created. The filing modestly increases the director’s ownership while maintaining his long-term exposure to the company.
On July 1, 2025, Hyster-Yale (HY) director David B. Williams reported the acquisition of 948 Class A common shares at a cost basis of $0 under the company’s Non-Employee Directors’ Equity Compensation Plan. Following the grant, Williams’ directly held position—maintained in a trust for his benefit—increased to 21,411 shares. The filing also lists extensive indirect holdings for Williams and related family trusts and partnerships, but these positions were unchanged; no sales or open-market purchases were disclosed. The transaction is routine director compensation rather than an elective purchase, making the overall market impact minimal.
Hyster-Yale (NYSE:HY) entered into a $300 million Third Amended & Restated revolving credit facility on 24 June 2025.
The agreement, split into $210 million domestic and $90 million foreign tranches, replaces a revolver due 2026 and now matures on 24 June 2030, with an accordion option up to $400 million.
- Collateral: first-priority lien on working-capital assets; second-priority on equity, fixtures and IP.
- Rates: U.S. base +0.25%–0.75% or SOFR/EURIBOR +1.25%–1.75%; introductory margins 0.50%/1.50% until 30 Jun 2025.
- Unused commitment fee: 0.25% p.a.
- Covenants limit extra debt, dividends and investments unless excess availability >10% of borrowing base or >$20 million and fixed-charge coverage tests are met.
The facility extends tenor, improves liquidity and offers upsize flexibility, but increases secured leverage and imposes tighter cash-return constraints.
FAQ
What is the current stock price of Hyster-Yale (HY)?
What is the market cap of Hyster-Yale (HY)?
